CD274 and cholangiocarcinoma: Moreover, as already reported in colorectal carcinoma, we observed enhanced PD-L1 expression by the microenvironment in cholangiocarcinomas with dense lymphocytic infiltrates, suggesting that these tumors stimulate the immune system and rely on the PD-L1/PD-1 pathway to escape antitumor immunity [24, 25].